Imbruvica and Fatigue - a phase IV clinical study of FDA data
Summary:
Fatigue is reported as a side effect among people who take Imbruvica (ibrutinib), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D, and have Chronic lymphocytic leukaemia.
The phase IV clinical study analyzes which people have Fatigue when taking Imbruvica. It is created by eHealthMe based on reports of 69,938 people who have side effects when taking Imbruvica from the FDA, and is updated regularly.
What is Imbruvica?
Imbruvica has active ingredients of ibrutinib. It is often used in chronic lymphocytic leukemia (cll). eHealthMe is studying from 70,020 Imbruvica users. Check the latest studies of Imbruvica.
What is Fatigue?
Fatigue (feeling of tiredness) is found to be associated with 4,028 drugs and 6,380 conditions by eHealthMe. Check the latest studies of Fatigue.
69,938 people reported to have side effects when taking Imbruvica.
Among them, 5,463 people (7.81%) have Fatigue.
Among these 5,463 people:
How long have people been on Imbruvica when they have Fatigue? *
What is the gender of people who have Fatigue when taking Imbruvica? *
What is the age of people who have Fatigue when taking Imbruvica? *
What are other drugs people take besides Imbruvica? *
What are other side effects people have besides Fatigue? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Imbruvica and have Fatigue?
- Check whether Fatigue is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Imbruvica:
- Imbruvica (70,020 reports)
Fatigue treatments and more:
- Fatigue (967,537 reports)
How severe was Fatigue and when was it recovered:
Expand to all the drugs that have ingredients of ibrutinib:
- Fatigue and drugs with ingredients of ibrutinib (5,942 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Imbruvica:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Fatigue:
- Fatigue (4,028 drugs)
Browse all the conditions that are associated with Fatigue:
- Fatigue (6,380 conditions)
Related publications that referenced our studies
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on ibrutinib (the active ingredients of Imbruvica) and Imbruvica (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nephrogenic Anaemia and Musculoskeletal Pain - 7 seconds ago
- Budesonide and Disease Progression for Men aged 60+ - 15 seconds ago
- Drug interactions of Lanoxin and Colcrys - 21 seconds ago
- Drug interactions of Iron Dextran and Valium - 32 seconds ago
- Could Dactinomycin cause Metastases To Lymph Nodes? - 36 seconds ago
- Respiratory Distress Syndrome (Rds) In Infants and drugs of ingredients of magnesium - 39 seconds ago
- Could Aripiprazole cause Skin Blushing/Flushing? - 39 seconds ago
- Drug interactions of Pantoprazole Sodium and Tamsulosin Hydrochloride - 42 seconds ago
- Rituxan and Shock - Anaphylactic for Women aged 50-59 - a minute ago
- Rituxan and Anaphylactic Shock for Women aged 50-59 - a minute ago